Conference abstract
Conference abstractPublished 21 Oct 2013
Cytomegalovirus replication and outcome of patients with B-cell lymphoma undergoing allogeneic hematopoietic stem cell transplantation
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
This lecture will address the debated role of cytomegalovirus (CMV) replication for the outcome of patients with B-cell lymphomas undergoing allogeneic hematopoietic stem cell transplantation (HSCT). CMV replication can cause multi-organ disease, which is usually associated with acute or chronic graft-versus-host-disease (GVHD), suppression of graft hemopoiesis and immunosuppression, and eventually results in higher non-relapse mortality (NRM). However, it was recently reported that post-transplant CMV replication was associated with a reduced risk of relapse for patients with acute myeloid leukemia. We therefore investigated the role of CMV replication in a retrospective cohort, from seven different Italian institutions, of 200 patients with B-cell lymphomas and transplanted with a similar conditioning regimen comprising the association of thiotepa and cyclophosphamide. In univariate analysis we found that CMV replication was associated with a reduced risk of lymphoma relapse especially for patients transplanted from a HLA identical sibling and with a disease in complete remission post-transplant. Multivariate analysis showed a more complex role for CMV replication that substantially influenced the NRM rate. This lecture will focus also on recent findings of different subsets of the immune-system activated by CMV replication and that might be involved in the reduced relapse rate of lymphoma patients. In particular the lecture will focus on NK and gamma-delta T cells and will propose some pre-clinical mouse models to investigate the potential connection between CMV replication and graft versus lymphoma (GVL) effect.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 2018
Desensitization of HLA donor-specific antibodies results in high engraftment rates in patient undergoing allogeneic hematopoietic stem cell transplantation
Conference abstract · 2018
IMPACT OF HLA-G POLYMORPHISM ON THE OUTCOME OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR METASTATIC RENAL CELL CARCINOMA
Opinion · 1 Apr 2024
Assessment of COVID-19 Vaccine Efficacy in Recipients of Allogeneic Hematopoietic Stem Cell Transplants: An Analysis of Booster Strategies
Commentary · 5 Oct 2021
To Remember the Importance of both Donor Choice and HLA Matching to Reduce Morbidity and Mortality after Allogeneic Hematopoietic Stem Cell Transplant (HSCT)
More from this journal
The newest in Cancer Science & Therapy.
Commentary · 21 Feb 2026
Functional Immune Biomarker Identification in Patients with Breast Cancer
Perspective · 21 Feb 2026
Finding Potential Passerini Adducts for Anticancer Drug Development
Perspective · 21 Feb 2026
Head and Neck Cutaneous Squamous Cell Carcinoma with Perineural Invasion
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCancer Science & Therapy
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Jacopo Mariotti”

